Get all your news in one place.
100's of premium titles.
One app.
Start reading
Bangkok Post
Bangkok Post
World

'Breakthrough' mRNA cancer drug curbs melanoma in large trial

The companies said they would present their data at an upcoming international conference and begin filings with regulators for approval

WASHINGTON (UNITED STATES) - US drugmakers Merck and Moderna said Wednesday a personalized cancer treatment had shown success in reducing the recurrence of melanoma tumors in a late-stage trial hailed by experts as a "breakthrough."

The news sent shares in Moderna soaring 145 percent to $154 while Merck's stock was up more than 12 percent to $152.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.